Research output per year
Research output per year
Fingerprint
Dive into the research topics where Karolien Vekens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors
Vounckx, M., Tijtgat, J., Stevens, L., Dirven, I., Ilsen, B., Vandenbroucke, F., Raeymaeckers, S., Vekens, K., Forsyth, R., Geeraerts, X., Van Riet, I., Schwarze, J. K., Tuyaerts, S., Decoster, L., De Ridder, M., Dufait, I. & Neyns, B., 2 Jul 2024, In: Cancer Immunol Immunother. 73, 9, 8 p., 167.Research output: Contribution to journal › Article › peer-review
Open AccessFile10 Downloads (Pure) -
Recurrence Risk and Its Impact on Current Treatment Strategies in Early and Locally Advanced NSCLC
Tegenbosch, C. & Vekens, K., Dec 2024, In: Anticancer Research. 44, 12, p. 5495-5500 6 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Features of post-obstructive pneumonia in advanced lung cancer patients, a large retrospective cohort
Moretti, M., Wellekens, S., Dirkx, S., Vekens, K., Van Laethem, J., Ilsen, B. & Vanderhelst, E., Feb 2023, In: Infectious diseases (London, England). 55, 2, p. 149-157 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)173 Downloads (Pure) -
Identification of novel biomarkers for long-term response on immunotherapy in non-small cell lung cancer patients
De Ridder, K., Nazari, S., Giron, P., Vekens, K. L. K., Locy, H., Waelput, W., Goyvaerts, C. & Decoster, L., 3 May 2023, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
1096P Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)
Decoster, L., De Ridder, K., Nazari, S., Giron, P., Vekens, K. L. K. & Goyvaerts, C., 9 Sept 2022, In: Annals of Oncology. 33, 7, p. 1052-1052 1 p.Research output: Contribution to journal › Meeting abstract (Journal)
Prizes
-
Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer
Vekens, Karolien (Recipient), 30 May 2018
Prize: Prize (including medals and awards)
-
Immunotherapy based (neo)adjuvant therapy in resectable NSCLC
Karolien Vekens (Speaker)
11 Mar 2024Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Identification of primary and acquired resistance mechanisms in non-small-cell lung cancer to T-cell mediated killing.
Kirsten De Ridder (Speaker), Thomas Benoot (Contributor), Philippe Giron (Contributor), Sohrab Nazari (Contributor), Karolien Vekens (Contributor), Lore Decoster (Contributor) & Cleo Goyvaerts (Contributor)
25 Jan 2024 → 28 Jan 2024Activity: Talk or presentation › Talk or presentation at a conference
-
ELCC 2024 Highlights
Karolien Vekens (Speaker)
31 Mar 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Identification of novel biomarkers for long-term response on immunotherapy in non-small cell lung cancer patients
Kirsten De Ridder (Speaker), Philippe Giron (Contributor), Sohrab Nazari (Contributor), Karolien Leona K Vekens (Contributor), Cleo Goyvaerts (Contributor) & Lore Decoster (Contributor)
10 Nov 2023 → 12 Nov 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Driver mutations in NSCLC
Karolien Leona K Vekens (Speaker)
18 Oct 2021Activity: Talk or presentation › Talk or presentation at a conference